Agnieszka R.
- Country
- Poland
- Department
- NA
Research Overview
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Oral Enpatoran in Adults With Active Cutaneous Lupus Erythematosus (with or without systemic disease)
- Efficacy and Safety of Gliclazide MR and Dapagliflozin, with or without Metformin, in Type 2 Diabetes Patients Inadequately Controlled on Dapagliflozin
- Efficacy and Safety Evaluation of Pioglitazone with Metformin and Empagliflozin in Type 2 Diabetes Mellitus Patients with Inadequate Glycemic Control
Data & Insights
Has run more than one trial at 4 of 163 partner sites.
Specializations
Diabetes Management
The investigator specializes in advanced therapeutic approaches for type 2 diabetes mellitus, with particular focus on combination therapy strategies. Their research encompasses the evaluation of various antidiabetic medications including gliclazide MR, dapagliflozin, and pioglitazone.
- Glycemic Control Optimization
- SGLT2 Inhibitor Therapies
- Combination Treatment Approaches
Their work specifically addresses inadequate glycemic control scenarios and explores enhanced treatment options for patients not achieving optimal results with standard therapies.
Infectious Disease Prevention
The investigator conducts research in influenza prevention, particularly focusing on enhanced vaccine strategies for elderly populations. Their work involves the evaluation of adjuvanted vaccine technologies aimed at improving immune responses in adults aged 65 and older.
- Vaccine Efficacy Studies
- Immunogenicity Assessment
- Elderly Population Healthcare
Their research specifically examines comparative effectiveness between adjuvanted and non-adjuvanted influenza vaccines.
Rheumatology
The investigator explores innovative treatments for rheumatoid arthritis, focusing on patients with moderate to severe disease manifestations. Their research involves evaluating novel biological therapies, particularly burfiralimab, in combination with conventional disease-modifying treatments.
- Biological Therapy Assessment
- Treatment-Resistant RA
- Combined Therapeutic Approaches
Their work specifically addresses the needs of patients who have shown inadequate response to traditional DMARD therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.